Spirometer

WhatsApp Order

A Spirometer is an essential diagnostic medical device used to measure how much and how quickly air can be inhaled and exhaled by the lungs. By performing forced breathing maneuvers, it generates key parameters—primarily Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 second (FEV1)—that are fundamental for diagnosing and monitoring obstructive and restrictive lung diseases like Asthma and COPD. Requiring daily calibration and strict adherence to international standards (ATS/ERS), it provides the objective, reproducible data needed for clinical decision-making in pulmonology, primary care, occupational health, and pre-operative assessment.

Categories: DIAGNOSTIC EQUIPMENT, Spirometers and Pulmonary Function Tests Tags: AsthmaDiagnosis, COPD, LungFunction, PFT, PulmonaryFunctionTest, RespiratoryTherapy, Spirometer

Description

Spirometer

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Diagnosis & Assessment of Obstructive Lung Diseases:

Primary Use: The primary diagnostic tool for identifying and evaluating the severity of airflow limitation in conditions such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis, and Emphysema. It quantifies the degree of obstruction.
How it helps: Provides objective, measurable evidence of how well air moves in and out of a patient’s lungs, distinguishing between normal breathing and the airway narrowing that characterizes obstructive lung diseases.

2. Diagnosis & Assessment of Restrictive Lung Diseases:

Primary Use: Essential for detecting restrictive patterns caused by conditions like Pulmonary Fibrosis, Sarcoidosis, Chest Wall Disorders (e.g., kyphoscoliosis), Neuromuscular Diseases (e.g., ALS, Myasthenia Gravis), and post-surgical states.
How it helps: Reveals when lung volumes are reduced by scarring, chest wall deformities, or muscle weakness, helping doctors identify the cause of shortness of breath in patients whose airways are not obstructed.

3. Pre-operative Pulmonary Risk Assessment:

Primary Use: Routinely performed before major surgeries (especially thoracic and abdominal) to identify patients with undiagnosed lung disease who are at increased risk for post-operative pulmonary complications.
How it helps: Helps surgeons and anesthesiologists identify patients whose lungs may struggle after surgery, allowing them to take precautions and optimize lung health before proceeding with operations.

4. Monitoring Disease Progression & Treatment Efficacy:

Primary Use: Used to objectively track the natural history of chronic lung diseases and to assess the response to medications (e.g., bronchodilators, inhaled corticosteroids) through serial measurements.
How it helps: Gives patients with chronic lung disease and their pulmonologists objective data on whether treatments are working and how their disease is progressing over time, guiding adjustments to therapy.

5. Disability & Impairment Evaluation:

Primary Use: Provides objective data for evaluating respiratory impairment in occupational lung diseases (e.g., asbestosis, silicosis) and for disability claims.
How it helps: Offers objective evidence of lung impairment that can support disability claims and workers’ compensation cases, ensuring patients receive the benefits they deserve for work-related lung damage.

SECONDARY & SUPPORTIVE USES

1. Screening in High-Risk Populations: Used to screen individuals with a history of smoking, occupational exposure to lung irritants, or a family history of lung disease, catching problems early when interventions can be most effective.

2. Bronchodilator Responsiveness Testing: A key test to determine if airway obstruction is reversible (a hallmark of asthma), by comparing spirometry results before and after administering a short-acting bronchodilator, guiding treatment decisions.

3. Cardiopulmonary Exercise Testing: Integrated into full exercise tests to evaluate ventilatory limitations during physical activity, helping distinguish between cardiac and pulmonary causes of exercise intolerance.

4. Public Health & Epidemiological Research: The standard instrument for large-scale studies on lung health and the prevalence of respiratory diseases in populations, contributing to public health policy and research.

5. Athlete Assessment: Used in sports medicine to evaluate lung function in athletes, establishing baselines and identifying any underlying respiratory limitations that might affect performance.

KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

Device Type: Pulmonary Function Testing (PFT) Device.
Core Measurement: Records the volume of air inhaled and exhaled by the lungs over time.
Types:
- Office Spirometer: Compact device for primary care settings, measuring key parameters like FEV1 and FVC.
- Diagnostic/Lab Spirometer: A more advanced system, often part of a full PFT suite, providing comprehensive flow-volume loops and additional lung volumes.
- Incentive Spirometer: A simple, disposable device used post-operatively to encourage deep breathing and prevent atelectasis (lung collapse). (Note: This is a different therapeutic device, not a diagnostic one.)
Output: Produces numerical results and graphical plots (spirogram and flow-volume loop).

2. TECHNICAL & PERFORMANCE PROPERTIES

Key Parameters Measured:
- Forced Vital Capacity (FVC): The total volume of air exhaled with maximal effort after a full inhalation.
- Forced Expiratory Volume in 1 second (FEV1): The volume of air exhaled in the first second of the FVC maneuver. The FEV1/FVC ratio is the critical index for distinguishing obstructive from restrictive disease.
- Peak Expiratory Flow (PEF): The maximum flow rate achieved during the FVC maneuver.
- Forced Expiratory Flow (FEF 25-75%): The average flow during the middle half of the FVC, indicating small airway function.
Accuracy & Standards: Must meet stringent performance criteria set by international bodies:
- American Thoracic Society (ATS) / European Respiratory Society (ERS) standards define accuracy, repeatability, and calibration requirements.
- Accuracy: Typically within ±3% or 0.050 L, whichever is greater.
Calibration: Requires daily volume calibration using a 3-liter calibration syringe and regular biological control checks to ensure accuracy.
Predicted Values: Software includes reference equations (based on age, height, sex, and ethnicity) to calculate predicted normal values for comparison.

3. PHYSICAL & OPERATIONAL PROPERTIES

Flow Sensor Technology: Uses a pneumotachograph, ultrasonic sensor, or turbine to measure airflow, which is integrated to calculate volume.
Disposable Components: Uses disposable mouthpieces, filters, and tubing for hygiene. The filter prevents microbial contamination of the device.
Connectivity: Modern devices connect to computers or tablets via USB or Bluetooth for software analysis, data storage, and report printing.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Approvals: FDA 510(k) Cleared (USA) and CE Marked (EU) as a Class II medical device.
Quality Standards: Manufactured under ISO 13485.
Software Compliance: Software for interpretation may be regulated and should comply with data protection standards (e.g., HIPAA).

5. STORAGE & HANDLING ATTRIBUTES

Storage: Store in a clean, dry, temperature-stable environment. Protect from dust and physical impact.
Cleaning & Disinfection:
- External: Wipe the main unit with a disinfectant cloth.
- Internal Pathway: According to manufacturer instructions; often involves running a disinfectant solution through the tubing or using specific cleaning modes. Never autoclave the main unit.
Calibration Schedule: Perform 3-liter syringe volume calibration daily before use. Perform leak tests and biological control checks weekly or as per protocol.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: The cornerstone of pulmonary function testing, providing objective, quantifiable data for the diagnosis and management of respiratory diseases.
Interpretation: Results must be interpreted by a trained clinician in the context of the patient's history, physical exam, and other tests.

SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

Contraindications: Should not be performed on patients with recent myocardial infarction, unstable angina, pneumothorax, recent thoracic or abdominal surgery, or severe hemoptysis.
Infection Control: Use a new disposable mouthpiece and filter for each patient. Follow strict disinfection protocols for reusable components.
Patient Instruction: Proper technique is critical. The operator must give clear, forceful coaching to ensure a valid test. Poor effort invalidates results.
Biohazard: The exhalation filter may contain pathogenic microorganisms and should be disposed of as biohazardous waste.

2. FIRST AID MEASURES

Patient Distress: If a patient experiences severe dizziness, chest pain, or syncope during the test, stop immediately, have them sit or lie down, and monitor. Administer oxygen if indicated and available.
Device Malfunction: If the device provides erratic readings or fails, discontinue use and replace with a calibrated backup device.

3. FIRE FIGHTING MEASURES

Flammability: Plastic housing and electronic components are combustible.
Extinguishing Media: For electrical fires, use a CO₂ or dry chemical extinguisher.

Spirometer

Spirometer

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Diagnosis & Assessment of Obstructive Lung Diseases:

Primary Use: The primary diagnostic tool for identifying and evaluating the severity of airflow limitation in conditions such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis, and Emphysema. It quantifies the degree of obstruction.

How it helps: Provides objective, measurable evidence of how well air moves in and out of a patient’s lungs, distinguishing between normal breathing and the airway narrowing that characterizes obstructive lung diseases.

2. Diagnosis & Assessment of Restrictive Lung Diseases:

Primary Use: Essential for detecting restrictive patterns caused by conditions like Pulmonary Fibrosis, Sarcoidosis, Chest Wall Disorders (e.g., kyphoscoliosis), Neuromuscular Diseases (e.g., ALS, Myasthenia Gravis), and post-surgical states.

How it helps: Reveals when lung volumes are reduced by scarring, chest wall deformities, or muscle weakness, helping doctors identify the cause of shortness of breath in patients whose airways are not obstructed.

3. Pre-operative Pulmonary Risk Assessment:

Primary Use: Routinely performed before major surgeries (especially thoracic and abdominal) to identify patients with undiagnosed lung disease who are at increased risk for post-operative pulmonary complications.

How it helps: Helps surgeons and anesthesiologists identify patients whose lungs may struggle after surgery, allowing them to take precautions and optimize lung health before proceeding with operations.

4. Monitoring Disease Progression & Treatment Efficacy:

Primary Use: Used to objectively track the natural history of chronic lung diseases and to assess the response to medications (e.g., bronchodilators, inhaled corticosteroids) through serial measurements.

How it helps: Gives patients with chronic lung disease and their pulmonologists objective data on whether treatments are working and how their disease is progressing over time, guiding adjustments to therapy.

5. Disability & Impairment Evaluation:

Primary Use: Provides objective data for evaluating respiratory impairment in occupational lung diseases (e.g., asbestosis, silicosis) and for disability claims.

How it helps: Offers objective evidence of lung impairment that can support disability claims and workers’ compensation cases, ensuring patients receive the benefits they deserve for work-related lung damage.

SECONDARY & SUPPORTIVE USES

1. Screening in High-Risk Populations: Used to screen individuals with a history of smoking, occupational exposure to lung irritants, or a family history of lung disease, catching problems early when interventions can be most effective.

2. Bronchodilator Responsiveness Testing: A key test to determine if airway obstruction is reversible (a hallmark of asthma), by comparing spirometry results before and after administering a short-acting bronchodilator, guiding treatment decisions.

3. Cardiopulmonary Exercise Testing: Integrated into full exercise tests to evaluate ventilatory limitations during physical activity, helping distinguish between cardiac and pulmonary causes of exercise intolerance.

4. Public Health & Epidemiological Research: The standard instrument for large-scale studies on lung health and the prevalence of respiratory diseases in populations, contributing to public health policy and research.

5. Athlete Assessment: Used in sports medicine to evaluate lung function in athletes, establishing baselines and identifying any underlying respiratory limitations that might affect performance.

1. BASIC IDENTIFICATION ATTRIBUTES

Device Type: Pulmonary Function Testing (PFT) Device.

Core Measurement: Records the volume of air inhaled and exhaled by the lungs over time.

Types:

Office Spirometer: Compact device for primary care settings, measuring key parameters like FEV1 and FVC.

Diagnostic/Lab Spirometer: A more advanced system, often part of a full PFT suite, providing comprehensive flow-volume loops and additional lung volumes.

Incentive Spirometer: A simple, disposable device used post-operatively to encourage deep breathing and prevent atelectasis (lung collapse). (Note: This is a different therapeutic device, not a diagnostic one.)

Output: Produces numerical results and graphical plots (spirogram and flow-volume loop).

2. TECHNICAL & PERFORMANCE PROPERTIES

Key Parameters Measured:

Forced Vital Capacity (FVC): The total volume of air exhaled with maximal effort after a full inhalation.

Forced Expiratory Volume in 1 second (FEV1): The volume of air exhaled in the first second of the FVC maneuver. The FEV1/FVC ratio is the critical index for distinguishing obstructive from restrictive disease.

Peak Expiratory Flow (PEF): The maximum flow rate achieved during the FVC maneuver.

Forced Expiratory Flow (FEF 25-75%): The average flow during the middle half of the FVC, indicating small airway function.

Accuracy & Standards: Must meet stringent performance criteria set by international bodies:

American Thoracic Society (ATS) / European Respiratory Society (ERS) standards define accuracy, repeatability, and calibration requirements.

Accuracy: Typically within ±3% or 0.050 L, whichever is greater.

Calibration: Requires daily volume calibration using a 3-liter calibration syringe and regular biological control checks to ensure accuracy.

Predicted Values: Software includes reference equations (based on age, height, sex, and ethnicity) to calculate predicted normal values for comparison.

3. PHYSICAL & OPERATIONAL PROPERTIES

Flow Sensor Technology: Uses a pneumotachograph, ultrasonic sensor, or turbine to measure airflow, which is integrated to calculate volume.

Disposable Components: Uses disposable mouthpieces, filters, and tubing for hygiene. The filter prevents microbial contamination of the device.

Connectivity: Modern devices connect to computers or tablets via USB or Bluetooth for software analysis, data storage, and report printing.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Approvals: FDA 510(k) Cleared (USA) and CE Marked (EU) as a Class II medical device.

Quality Standards: Manufactured under ISO 13485.

Software Compliance: Software for interpretation may be regulated and should comply with data protection standards (e.g., HIPAA).

5. STORAGE & HANDLING ATTRIBUTES

Storage: Store in a clean, dry, temperature-stable environment. Protect from dust and physical impact.

Cleaning & Disinfection:

External: Wipe the main unit with a disinfectant cloth.

Internal Pathway: According to manufacturer instructions; often involves running a disinfectant solution through the tubing or using specific cleaning modes. Never autoclave the main unit.

Calibration Schedule: Perform 3-liter syringe volume calibration daily before use. Perform leak tests and biological control checks weekly or as per protocol.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: The cornerstone of pulmonary function testing, providing objective, quantifiable data for the diagnosis and management of respiratory diseases.

Interpretation: Results must be interpreted by a trained clinician in the context of the patient's history, physical exam, and other tests.

1. SAFETY PRECAUTIONS

Contraindications: Should not be performed on patients with recent myocardial infarction, unstable angina, pneumothorax, recent thoracic or abdominal surgery, or severe hemoptysis.

Infection Control: Use a new disposable mouthpiece and filter for each patient. Follow strict disinfection protocols for reusable components.

Patient Instruction: Proper technique is critical. The operator must give clear, forceful coaching to ensure a valid test. Poor effort invalidates results.

Biohazard: The exhalation filter may contain pathogenic microorganisms and should be disposed of as biohazardous waste.

2. FIRST AID MEASURES

Patient Distress: If a patient experiences severe dizziness, chest pain, or syncope during the test, stop immediately, have them sit or lie down, and monitor. Administer oxygen if indicated and available.

Device Malfunction: If the device provides erratic readings or fails, discontinue use and replace with a calibrated backup device.

3. FIRE FIGHTING MEASURES

Flammability: Plastic housing and electronic components are combustible.

Extinguishing Media: For electrical fires, use a CO₂ or dry chemical extinguisher.

Related products

BRANDS

FOLLOW US